Assessment of a Customized Mobile App for Reducing Fear of Breast Cancer Recurrence

Print

Full Title

Attention and Interpretation Modification (AIM) for Fear of Breast Cancer Recurrence: An Intervention Development Study

Purpose

The purpose of this study is to test a mobile app intervention called iThrive to help breast cancer survivors cope with the fear of recurrence. iThrive is designed to help patients reduce their fear of recurrence through the repeated practice of tasks designed to help shift mental habits that may be linked to increased anxiety.

Participants in this study will be randomly assigned to use iThrive and a symptom tracking app, or a symptom tracking app alone. Those assigned to iThrive will be asked to complete 8 or 16 sessions using the app. In addition, participants will complete questionnaires at the start of the study, after completing the intervention, and one month later to evaluate the apps.

Eligibility

Participants of the study are women age 18 and older who completed active treatment for early-stage breast cancer and are experiencing elevated levels of fear of recurrence.

For more information about this study, please contact the research staff at 646-888-0134 or AIMStudy@mskcc.org, or contact Dr. Wendy Lichtenthal at 646-888-4812.

Protocol

11-204

Phase

Pilot

Investigator